Clinical trial
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System: an Observational Pilot Study
NCT04410237 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System: an Observational Pilot Study
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 4, 2020
- Completion date
- May 19, 2023
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.